av/adicet-bio--big.svg

COM:ADICETBIO

Adicet Bio

  • Stock

Last Close

0.97

21/11 21:00

Market Cap

104.36M

Beta: -

Volume Today

841.82K

Avg: -

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for ...Show More

peer of

investor of